Maimonides Children's Hospital, Brooklyn, New York.
Lewisham and Greenwich NHS Trust, London, United Kingdom.
Am J Trop Med Hyg. 2020 Apr;102(4):902-904. doi: 10.4269/ajtmh.19-0541.
Management of fever is a key element of care for children with sickle cell disease (SCD). There exist few studies of current practices in managing fevers in SCD in low- and middle-income countries (LMICs) and malaria-endemic regions where SCD is prevalent. We surveyed medical providers in these settings to characterize current practices in infection prevention and fever management for children with SCD. We found wide variation in use of newborn screening for early diagnosis and infection prevention, pneumococcal vaccination, use of antibiotics and antimalarials, and route of antibiotic administration. Counter to established guidelines, 78% (95% CI: 59-100%) of respondents would consider using oral antibiotics for a febrile child with SCD. Only 17% (95% CI: 0-37%) would administer antibiotics to a well-appearing child with a positive malaria test. Availability of blood cultures did not affect duration of antibiotic course. Further study and standardization of fever management in SCD in LMICs are urgently needed.
管理发热是镰状细胞病(SCD)患儿护理的关键环节。目前针对中低收入国家(LMICs)和疟疾流行地区 SCD 患儿发热管理的现行实践,仅有少量研究。我们对这些地区的医务人员进行了调查,以明确 SCD 患儿感染预防和发热管理的现行实践情况。我们发现,在新生儿筛查以进行早期诊断和感染预防、肺炎球菌疫苗接种、抗生素和抗疟药物的使用以及抗生素给药途径等方面,做法存在较大差异。与既定指南相悖的是,78%(95%置信区间:59-100%)的受访者会考虑为发热的 SCD 患儿使用口服抗生素。只有 17%(95%置信区间:0-37%)的受访者会给表现良好但疟原虫检测阳性的患儿使用抗生素。血培养的可用性并不影响抗生素疗程的长短。迫切需要进一步研究和规范 LMICs 中 SCD 的发热管理。